Hypomethylating Agent Therapy for Chronic Myelomonocytic Leukemia Does Not Impact Acute Myeloid Leukemia Transformation or Survival

被引：0
|
作者：
Niyongere, Sandrine
Kathari, Yamini
Singh, Zeba
Vannorsdall, Emily J.
Emadi, Ashkan
Vu Doung
Baer, Maria R.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] AN UNUSUAL ASSOCIATION OF THERAPY RELATED CHRONIC MYELOMONOCYTIC LEUKEMIA AND MLL REARRANGEMENT IN A CHILD TREATED FOR ACUTE MYELOID LEUKEMIA
    Catala, A.
    Torrebadell, M.
    Trabazo, M.
    Berrueco, R.
    Ruiz-Llobet, A.
    Perez-Iribarne, M.
    Plensa, I.
    Costa, D.
    Olive, T.
    Calvente, L.
    Mesegue, M.
    Alonso, A.
    Rives, S.
    Camos, M.
    HAEMATOLOGICA, 2015, 100 : 19 - 20
  • [32] Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
    Coston, Tucker
    Pophali, Prateek
    Vallapureddy, Rangit
    Lasho, Terra L.
    Finke, Christy M.
    Ketterling, Rhett P.
    Carr, Ryan
    Binder, Moritz
    Mangaonkar, Abhishek A.
    Gangat, Naseema
    Al-Kali, Aref
    Litzow, Mark
    Zblewski, Darci
    Pardanani, Animesh
    Tefferi, Ayalew
    Patnaik, Mrinal M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (07) : 767 - 779
  • [33] Comparable Survival of Treatment Naive TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy
    Badar, Talha
    Atallah, Ehab L.
    Shallis, Rory M.
    Patel, Anand Ashwin
    Correia, Guilherme Sacchi De Camargo
    Goldberg, Aaron D.
    Saliba, Antoine
    Bewersdorf, Jan Philipp
    Duvall, Adam S.
    Bradshaw, Danielle
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Palmisiano, Neil
    Kota, Vamsi K.
    Litzow, Mark R.
    BLOOD, 2023, 142
  • [34] Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
    Johnson, Isla McKerrow
    Ilyas, Rimal
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun, V
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2022, 140 : 3233 - 3234
  • [35] ATYPICAL CHRONIC MYELOID-LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA IN CHILDREN
    HASLE, H
    KERNDRUP, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) : 428 - 429
  • [36] Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis
    Vardell, Victoria A.
    Ose, Jennifer
    Rets, Anton, V
    Tantravahi, Srinivas K.
    Patel, Ami B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (12): : 843 - 851
  • [37] ANALYSIS OF FACTORS AFFECTING ACUTE TRANSFORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    MOLICA, S
    IANNACCARO, P
    ALBERTI, A
    HAEMATOLOGICA, 1990, 75 (03) : 303 - 304
  • [38] Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
    Bing Li
    Robert Peter Gale
    Zhijian Xiao
    Journal of Hematology & Oncology, 7
  • [39] Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
    Li, Bing
    Gale, Robert Peter
    Xiao, Zhijian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [40] HYPOMETHYLATING AGENTS DOES NOT IMPROVE OVERALL SURVIVAL IN PATIENTS DIAGNOSED WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) COMPARED TO HISTORICAL DATA
    Affakara, D.
    Hanson, C.
    Swedeh, A.
    Elliott, M.
    Hashmi, S.
    Wolanskyj, A.
    Hogari, W.
    Litzow, M.
    Al-Kali, A.
    HAEMATOLOGICA, 2013, 98 : 88 - 88
12345